Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations
PaperCitations, authors & open-access status
MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 126 citations, 2011 year and bronze oa status.
126
Citations
2011
Year
bronze
OA Status